Bleeding Disorders including Haemophilia B
NHS National Framework Agreement for the supply of products for the treatment of Bleeding Disorders including Haemophilia B. Period of framework agreement: 1 July 2022 to 30 June 2024 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. Total maximum framework agreement including extension options will be no more than 48 months
Buyer
NHS England
Value
£500,000,000
Published
20 Jul 2022
Closes
14 Feb 2022
Procurement details
Source
Contracts Finder
Region
London
Procurement method
Open
Category
Goods
Contract starts
30 Jun 2022
Contract ends
30 Jun 2024
CPV classifications
33141530
Blood coagulants
Lots
Lot default Bleeding Disorders including Haemophilia B
£250,000,000
NHS National Framework Agreement for the supply of products for the treatment of Bleeding Disorders including Haemophilia B. Period of framework agreement: 1 July 2022 to 30 June 2024 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. Total maximum framework agreement including extension op...
Delivery: England · United Kingdom, Guernsey, Isle of Man, Jersey, Northern Ireland · United Kingdom, Scotland · United Kingdom
Documents
Unlock document linkAwarded contract notice on Contracts Finder
5 Jul 2022
Awarded contract notice on Contracts Finder
Award notice · Web page
CF-09420 _ Salesforce - Enterprise Edition
Not provided
CF-09420 _ Salesforce - Enterprise Edition
Document
Document No. 03 - Framework Agreement and Terms and Conditions (REDACTED)
Not provided
Document No. 03 - Framework Agreement and Terms and Conditions (REDACTED)
Document
FTS Award Notice - Supply of products for the treatment of Bleeding Disorders, including Haemophilia B
Not provided
FTS Award Notice - Supply of products for the treatment of Bleeding Disorders, including Haemophilia B
Document
Bio Products Laboratory Ltd - AWARD SCHEDULE (REDACTED)
Not provided
Bio Products Laboratory Ltd - AWARD SCHEDULE (REDACTED)
Document
CSL Behring UK Ltd - AWARD SCHEDULE (REDACTED)
Not provided
CSL Behring UK Ltd - AWARD SCHEDULE (REDACTED)
Document
LFB Biopharmaceuticals Ltd - AWARD SCHEDULE (REDACTED)
Not provided
LFB Biopharmaceuticals Ltd - AWARD SCHEDULE (REDACTED)
Document
Novo Nordisk Ltd - AWARD SCHEDULE (REDACTED)
Not provided
Novo Nordisk Ltd - AWARD SCHEDULE (REDACTED)
Document
Awarded Suppliers - Name, Postcode and SME Indicator
Not provided
Awarded Suppliers - Name, Postcode and SME Indicator
Document
Octapharma Ltd - AWARD SCHEDULE (REDACTED)
Not provided
Octapharma Ltd - AWARD SCHEDULE (REDACTED)
Document
Pfizer Ltd - AWARD SCHEDULE (REDACTED)
Not provided
Pfizer Ltd - AWARD SCHEDULE (REDACTED)
Document
Swedish Orphan Biovitrum Ltd (Sobi Ltd) - AWARD SCHEDULE (REDACTED)
Not provided
Swedish Orphan Biovitrum Ltd (Sobi Ltd) - AWARD SCHEDULE (REDACTED)
Document
Contains public sector information licensed under the Open Government Licence v3.0.